Monday, 23 September 2019

H. Spectrum initiates collaboration for biomedical innovation

17 September 2018 | News

Global giants Bayer, Merck, and GE Ventures will be coming on aboard, and will collaborate with H. Spectrum.

Image credit- bostonmagazine.com

Image credit- bostonmagazine.com

Asia's largest biomedical accelerator, H. Spectrum is planning to collaborate with five major companies on a range of innovative medical technologies. This announcement was made during the Trans 2018 digital health conference held in Taipei on September 8-9.

Global giants Bayer, Merck, and GE Ventures will be coming on aboard, and will collaborate with H. Spectrum on applications of artificial intelligence, and to explore new opportunities with U.S. tech company NVIDIA.

H. Spectrum has signed the strategic partnership during the Trans 2018 digital health conference, which was organized by H. Spectrum and Foxconn. The conference brought together some of the world's most influential biomedical, venture capital, and medical companies.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls